Companies / Spruce Biosciences, Inc.

Spruce Biosciences, Inc.

Nasdaq: SPRBCIK 1683553SOUTH SAN FRANCISCO, CA

Financials · FY2025

Revenue$0
Net income$-38.97M
Total debt$19.94M
Cash$96.30M
Diluted EPS$-50.83
Shares outstanding2.9M

Ownership

2.9M shares outstanding · as of Aug 10, 2026
0.66%Insiders
Ownership
Insiders0.66%19,004
10%+ / strategic2.15%61,670
Institutions44.87%1,289,506
Public float52.33%1,503,833

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 5

View all →
Insider% of sharesShares
Szwarcberg Javier B.CEOCHIEF EXECUTIVE OFFICER · Director
0.66%19,004
Ways Douglas KirkFormerInterim Chief Medical Officer · Director
0.04%1,250
Grey Michael GExecutive Chairman · Director
——
Hooks Corwin DaleFormerChief Commercial Officer
——
Spiegelman Daniel KDirector
——

Institutional holders 36

View all →
HolderValue% of shares
AIGH Capital Management LLC$13.50M8.70%
Ikarian Capital, LLC$10.57M4.22%
BlackRock, Inc.$10.14M6.54%
Millennium Management LLC$7.31M3.89%
Squadron Master Fund LP$6.10M2.44%
Citadel Advisors LLC$6.10M2.44%
Wellington Management Group LLP$5.14M2.05%
ADAR1 Capital Management, LLC$5.05M2.02%
Alyeska Investment Group, L.P.$4.50M1.80%
Boothbay Fund Management, LLC$4.18M1.67%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Dec 31, 2025Szwarcberg Javier B.
CEO
GrantCommon Stock$21.2K+5K
+32.77%
19,004
0.66% of shares
low
Dec 11, 2025Ways Douglas Kirk
Executive
ExerciseCommon Stock$0+1K
1,250
0.04% of shares
low
May 21, 2026Grey Michael G
Executive
GrantStock Option (Right to Buy)—+2K
1,700
0.06% of shares
low
May 21, 2026Spiegelman Daniel K
Director
GrantStock Option (Right to Buy)—+2K
1,700
0.06% of shares
low
Mar 9, 2026Hooks Corwin Dale
Executive
GrantRestricted Stock Units—+11K
11,000
0.38% of shares
low
Dec 11, 2025Ways Douglas Kirk
Executive
OtherStock Option (Right to Buy)—-400
-100.00%
0
0.00% of shares
low
Dec 11, 2025Ways Douglas Kirk
Executive
GrantStock Option (Right to Buy)—+400
400
0.01% of shares
low
Dec 11, 2025Ways Douglas Kirk
Executive
OtherStock Option (Right to Buy)—-266
-100.00%
0
0.00% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Integrated Core Strategies (US) LLCPassive13G———
Citadel Advisors LLCPassive13G/A———
Alyeska Investment Group, L.P.Passive13G—61,670—
Squadron Master Fund LPPassive13G/A———
Wellington Management Group LLPPassive13G———
ADAR1 Capital Management, LLCPassive13G———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
SPRBCommon StockEquity85209E208BBG00HYZ1522